InTone for Urinary Incontinence
Primary Purpose
Urinary Incontinence
Status
Unknown status
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
InToneTM (InControl Medical, LLC) - Medical Device
Sponsored by
About this trial
This is an interventional treatment trial for Urinary Incontinence focused on measuring Urinary Incontinence, Stress Urinary Incontinence, Urge Incontinence, Mixed Urinary Incontience, Female Pelvic Health
Eligibility Criteria
Inclusion Criteria:
- Female gender
- Between ages 18-70
- Diagnosed with Stress Urinary Incontinence (SUI), Urge Urinary Incontinence (UUI), or Mixed Urinary Incontinence (MUI)
Exclusion Criteria:
- Incontinence of less than 6 months
- pregnancy or delivery within 6 weeks
- vaginal or pelvic surgery within previous 6 months
- pelvic organ prolapse greater than stage 2 (based on POP-Q)
- active UTI or history of recurrent UTIs (more than 3 in a year)
- recurrent vaginitis (bacterial/fungal)
- pelvic pain/painful bladder syndrome
- implanted cardiac device or untreated cardiac arrhythmi
- Underlying neurologic/neuromuscular disorder, or inadequate vaginal caliber (can't accommodate device).
Sites / Locations
- University Health Network (Altum Health)Recruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Intervention
Arm Description
Participants will undergo the InTone TM (InControl Medical, LLC) medical device treatment for Urinary Incontinence. The frequency of treatment is once/day (12 minutes), 5-6 days/week. The route of administration is vaginal.
Outcomes
Primary Outcome Measures
Pad Test Weighting
urine voiding measure
Secondary Outcome Measures
Urinary Distress Inventory (UDI-6)
Questionnaire that assesses symptom distress and the impact on daily life of urinary incontinence
Incontinence Impact Questionnaire Short Form (IIQ-7)
Assesses symptom distress and the impact on daily life of urinary incontinence
Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire (PISQ-12)
Evaluates sexual function in women with pelvic organ prolapse and/or urinary incontinence.
Urinary Incontinence Quality of Life Scale (IQOL)
A self-reported quality of life measure specific to urinary incontinence (UI),
International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ UI SF)
A subjective measure of severity of urinary loss and quality of life for those with urinary incontinence.
48 Hour Bladder Diary
A diary containing details of every void. The time, amount leaked and activity during the leakage are recorded for 48 hours.
Full Information
NCT ID
NCT02543242
First Posted
September 3, 2015
Last Updated
September 4, 2015
Sponsor
University Health Network, Toronto
1. Study Identification
Unique Protocol Identification Number
NCT02543242
Brief Title
InTone for Urinary Incontinence
Official Title
Effectiveness of the Intone Pelvic Floor Device for Urinary Incontinence
Study Type
Interventional
2. Study Status
Record Verification Date
September 2015
Overall Recruitment Status
Unknown status
Study Start Date
August 2015 (undefined)
Primary Completion Date
September 2016 (Anticipated)
Study Completion Date
September 2016 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Health Network, Toronto
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The rationale for the conduct of this study is that the Intone device (along with pelvic physiotherapy) can be used to help females suffering from urinary stress incontinence by using electrical stimulation and biofeedback during pelvic floor muscle training. This investigation is important because it can aid in the greater acceptance and development of non-surgical treatments for Stress Urinary Incontinence if these areas are looked into. The study results will address if the Intone device is beneficial and promotes long-term improvement in women that suffer from urinary incontinence.
Detailed Description
Urinary incontinence is very common in women and is linked to a reduced quality of life (Corcos et al., 2002). The three main types of urinary incontinence are Stress Urinary Incontinence (SUI), Urge Urinary Incontinence (UUI) and Mixed Urinary Incontinence (MUI). SUI and UUI involve losing urine involuntarily. In SUI this is during either effortful motion such as coughing or sneezing, or in UUI is associated with a feeling of urgency. Urinary incontinence has various treatment options including: surgery, medication, pelvic floor muscle exercises and electrical stimulation (Norton & Brubaker, 2006).
The most common physiotherapy treatment used for women with urinary incontinence is pelvic floor muscle training (Dumoulin & Hay-Smith, 2010). Several studies have investigated the effects of PFMT in comparison to other treatments such as no treatment and vaginal cones. They found that women in the PFMT group reported more improvement and better quality of life than women in other treatment groups. The PFMT group also had fewer daily incontinence episodes and less leakage (Bø, Talseth, & Holme, 1999; Dumoulin & Hay-Smith, 2010).
Electrical stimulation of the pelvic floor muscles is another treatment for urinary incontinence, and may often be combined with PFMT. Success rates of electrical stimulation in treating urinary incontinence range from 50-90% (Bent et al., 1993; Erikson, Bergmann, & Mjølnerød, 1987; Fall, 1984; Pelvnik et al., 1986).
A new product has been developed called InTone which combines PFMT, electrical stimulation and biofeedback. This device is inserted into the vagina and facilitates PFMT while providing electrical stimulation and biofeedback to the patient. This study will examine the effectiveness of the InTone device in treating urinary incontinence in women.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Urinary Incontinence
Keywords
Urinary Incontinence, Stress Urinary Incontinence, Urge Incontinence, Mixed Urinary Incontience, Female Pelvic Health
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
30 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Intervention
Arm Type
Experimental
Arm Description
Participants will undergo the InTone TM (InControl Medical, LLC) medical device treatment for Urinary Incontinence. The frequency of treatment is once/day (12 minutes), 5-6 days/week. The route of administration is vaginal.
Intervention Type
Device
Intervention Name(s)
InToneTM (InControl Medical, LLC) - Medical Device
Primary Outcome Measure Information:
Title
Pad Test Weighting
Description
urine voiding measure
Time Frame
up to 26 weeks
Secondary Outcome Measure Information:
Title
Urinary Distress Inventory (UDI-6)
Description
Questionnaire that assesses symptom distress and the impact on daily life of urinary incontinence
Time Frame
screening, Device Set up/Training Day, 2, 6, 14, 26 weeks from set up.
Title
Incontinence Impact Questionnaire Short Form (IIQ-7)
Description
Assesses symptom distress and the impact on daily life of urinary incontinence
Time Frame
screening, Device Set up/Training Day, 2, 6, 14, 26 weeks from set up.
Title
Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire (PISQ-12)
Description
Evaluates sexual function in women with pelvic organ prolapse and/or urinary incontinence.
Time Frame
screening, Device Set up/Training Day, 2, 6, 14, 26 weeks from set up.
Title
Urinary Incontinence Quality of Life Scale (IQOL)
Description
A self-reported quality of life measure specific to urinary incontinence (UI),
Time Frame
screening, Device Set up/Training Day, 2, 6, 14, 26 weeks from set up.
Title
International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ UI SF)
Description
A subjective measure of severity of urinary loss and quality of life for those with urinary incontinence.
Time Frame
screening, Device Set up/Training Day, 2, 6, 14, 26 weeks from set up.
Title
48 Hour Bladder Diary
Description
A diary containing details of every void. The time, amount leaked and activity during the leakage are recorded for 48 hours.
Time Frame
up to 6 months follow-up
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Female gender
Between ages 18-70
Diagnosed with Stress Urinary Incontinence (SUI), Urge Urinary Incontinence (UUI), or Mixed Urinary Incontinence (MUI)
Exclusion Criteria:
Incontinence of less than 6 months
pregnancy or delivery within 6 weeks
vaginal or pelvic surgery within previous 6 months
pelvic organ prolapse greater than stage 2 (based on POP-Q)
active UTI or history of recurrent UTIs (more than 3 in a year)
recurrent vaginitis (bacterial/fungal)
pelvic pain/painful bladder syndrome
implanted cardiac device or untreated cardiac arrhythmi
Underlying neurologic/neuromuscular disorder, or inadequate vaginal caliber (can't accommodate device).
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Dean S Elterman, MD
Email
dean.elterman@uhn.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dean S Elterman, MD
Organizational Affiliation
University Health Network, Toronto
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Health Network (Altum Health)
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5T 2S8
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Dean Elterman, MD
Email
dean.elterman@uhn.ca
First Name & Middle Initial & Last Name & Degree
Sara Jaffer, BSc
Email
sara.jaffer@uhn.ca
First Name & Middle Initial & Last Name & Degree
Dean Elterman, MD
First Name & Middle Initial & Last Name & Degree
Rajiv Gandhi, MD
First Name & Middle Initial & Last Name & Degree
Sidney Radomski, MD
First Name & Middle Initial & Last Name & Degree
Magdy Hassouna, MD
12. IPD Sharing Statement
Citations:
PubMed Identifier
9322620
Citation
Brubaker L, Benson JT, Bent A, Clark A, Shott S. Transvaginal electrical stimulation for female urinary incontinence. Am J Obstet Gynecol. 1997 Sep;177(3):536-40. doi: 10.1016/s0002-9378(97)70142-x.
Results Reference
background
PubMed Identifier
12187188
Citation
Corcos J, Beaulieu S, Donovan J, Naughton M, Gotoh M; Symptom Quality of Life Assesment Committee of the First International Consultation on Incontinence. Quality of life assessment in men and women with urinary incontinence. J Urol. 2002 Sep;168(3):896-905. doi: 10.1016/S0022-5347(05)64540-5.
Results Reference
background
PubMed Identifier
25408383
Citation
Dumoulin C, Hay-Smith J, Habee-Seguin GM, Mercier J. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women: a short version Cochrane systematic review with meta-analysis. Neurourol Urodyn. 2015 Apr;34(4):300-8. doi: 10.1002/nau.22700. Epub 2014 Nov 18.
Results Reference
background
PubMed Identifier
3493802
Citation
Eriksen BC, Bergmann S, Mjolnerod OK. Effect of anal electrostimulation with the 'Incontan' device in women with urinary incontinence. Br J Obstet Gynaecol. 1987 Feb;94(2):147-56. doi: 10.1111/j.1471-0528.1987.tb02342.x.
Results Reference
background
PubMed Identifier
6608590
Citation
Fall M. Does electrostimulation cure urinary incontinence? J Urol. 1984 Apr;131(4):664-7. doi: 10.1016/s0022-5347(17)50566-2.
Results Reference
background
PubMed Identifier
10024253
Citation
Bo K, Talseth T, Holme I. Single blind, randomised controlled trial of pelvic floor exercises, electrical stimulation, vaginal cones, and no treatment in management of genuine stress incontinence in women. BMJ. 1999 Feb 20;318(7182):487-93. doi: 10.1136/bmj.318.7182.487.
Results Reference
background
PubMed Identifier
16399154
Citation
Norton P, Brubaker L. Urinary incontinence in women. Lancet. 2006 Jan 7;367(9504):57-67. doi: 10.1016/S0140-6736(06)67925-7.
Results Reference
background
PubMed Identifier
8016945
Citation
Tjelum KB, Lose G, Abel I, Pedersen LM. [Electrostimulation of the pelvic floor muscles in urinary incontinence]. Ugeskr Laeger. 1994 Apr 11;156(15):2214-6. Danish.
Results Reference
background
Learn more about this trial
InTone for Urinary Incontinence
We'll reach out to this number within 24 hrs